SEC Form 4 · accession 0001615774-16-008882

Enumeral Biomedical Holdings, Inc. · ENUM

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Director

Period of report

Dec 9, 2016

Accepted (ET)

Dec 13, 2016 · 5:35 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001561551

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock	Dec 9, 2016	M	52,000	$0.125	A	120,882	D
Common Stock	holding	—	—		—	175,286	I	By BiologicB, LLC

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Common Stock Purchase Warrant^F2,F1	$2.00	Dec 9, 2016	P	13,000	A	—	Jul 30, 2019	Common Stock	13,000	13,000	D
Common Stock Purchase Warrant^F3,F1	$0.50	Dec 9, 2016	J	52,000	A	—	Dec 9, 2016	Common Stock	52,000	52,000	D
Common Stock Purchase Warrant^F3,F1	$0.50	Dec 9, 2016	M	52,000	D	—	Dec 9, 2016	Common Stock	52,000	0	D

F1The Common Stock Purchase Warrants (the "Warrants") are exercisable immediately.
F2The Reporting Person acquired the reported Warrants in a private sale transaction for cash consideration in the amount of $0.08 per warrant.
F3Pursuant to an Offer to Amend and Exercise launched by the Issuer on October 28, 2016 (as subsequently amended, the "Offering"), the exercise price of each Warrant tendered in the Offering was reduced to $0.50 per Warrant, and participants in the Offering received four shares for each Warrant tendered rather than one share. Pursuant to the terms of the Offering, the expiration date of tendered Warrants was accelerated to December 9, 2016. The Reporting Person tendered all of the Warrants beneficially owned in the Offering.